2,235
Views
8
CrossRef citations to date
0
Altmetric
Reviews

Locoregional ablative treatment of melanoma metastases

, & ORCID Icon
Pages 59-63 | Received 30 Mar 2019, Accepted 07 Jun 2019, Published online: 20 Sep 2019

References

  • Corrie P, Hategan M, Fife K, et al. Management of melanoma. Br Med Bull. 2014;111:149–162.
  • Gupta A, Gome F, Lorigan P. The role for chemotherapy in the modern management of melanoma. Melanoma Manag. 2017;4:125–136.
  • Krantz BA, Dave N, Komatsubara KM, et al. Uveal melanoma: epidemiology, etiology, and treatment of primary disease. Clin Ophthalmol. 2017;11:279–289.
  • Kujala E, Mäkitie T, Kivelä T. Very long-term prognosis of patients with malignant uveal melanoma. Invest Ophthalmol Vis Sci. 2003;44:4651–4659.
  • Chattopadhyay C, Kim DW, Gombos DS, et al. Uveal melanoma: from diagnosis to treatment and the science in between. Cancer. 2016;122:2299–2312.
  • Augsburger JJ, Correa ZM, Shaikh AH. Effectiveness of treatments for metastatic uveal melanoma. Am J Ophthalmol. 2009;148:119–127.
  • Shashank A, Shehata M, Morris DL, et al. Radiofrequency ablation in metastatic melanoma. J Surg Oncol. 2014;109:366–369.
  • Brand CU, Ellwanger U, Stroebel W, et al. Prolonged survival of 2 years or longer for patients with disseminated melanoma. An analysis of related prognostic factors. Cancer. 1997;79:2345–2353.
  • Garbe C, Peris K, Hauschild A, et al. European consensus-based interdisciplinary guideline – update 2016. Eur J Cancer. 2016;63:201–217.
  • Dummer R, Hauschild A, Lindenblatt N, et al. Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015;26:v126–v132.
  • Holzwanger DJ, Madoff DC. Role of interventional radiology in the management of hepatocellular carcinoma: current status. Chin Clin Oncol. 2018;7:49.
  • Abdelaziz AO, Nabeel MM, Elbaz TM, et al. Microwave ablation versus transarterial chemoembolization in large hepatocellular carcinoma: prospective analysis. Scand J Gastroenterol. 2015;50:479–484.
  • Liu Y, Zheng Y, Li S, et al. Percutaneous microwave ablation of larger hepatocellular carcinoma. Clin Radiol. 2013;68:21–26.
  • Zhang NN, Lu W, Cheng XJ, et al. High-powered microwave ablation of larger hepatocellular carcinoma: evaluation of recurrence rate and factors related to recurrence. Clin Radiol. 2015;70:1237–1243.
  • Huang YZ, Zhou SC, Zhou H, et al. Radiofrequency ablation versus cryosurgery ablation for hepatocellular carcinoma: a meta-analysis. Hepatogastroenterology. 2013;60:1131–1135.
  • Pearson AS, Izzo F, Fleming RY, et al. Intraoperative radiofrequency ablation or cryoablation for hepatic malignancies. Am J Surg. 1999;178:592–599.
  • Stanislawska K, Stadnik H, Naqrocki M, et al. Long-term survival in a patient with unresectalbe liver metastases from uveal melanoma treatetd with transarterial chemoembolization with irinotecan eluting beads – case report and review of the literature. Contemp Oncol. 2018;21:244–248.
  • Ho C, McCormack S. Radioembolization with yttrium-90 microspheres for the management of uveal melanoma liver metastases: a review of clinical effectiveness and cost-effectiveness [Internet]. CADTH Rapid Response Reports. Ottawa: Canadian Agency for Drugs and Technologies in Health; 2018.
  • Bale R, Widmann G. Navigated CT-guided interventions. Minim Invasive Ther Allied Technol. 2007;16:196–204.
  • Bale R, Widmann G, Haidu M. Stereotactic radiofrequency ablation. Cardiovasc Intervent Radiol. 2011;34:852–856.
  • Bale R, Widmann G, Stoffner DI. Stereotaxy: breaking the limits of current radiofrequency ablation techniques. Eur J Radiol. 2010;75:32–36.
  • Bale R, Widmann G, Schullian P, et al. Percutaneous stereotactic radiofrequency ablation of colorectal liver metastases. Eur Radiol. 2012;22:930–937.
  • Haidu M, Dobrozemsky G, Schullian P, et al. Stereotactic radiofrequency ablation of unresectable intrahepatic cholangiocarcinomas: a retrospective study. Cardiovasc Intervent Radiol. 2012;35:1074–1082.
  • Ryu SW, Saw R, Scolyer RA, et al. Liver resection for metastatic melanoma: equivalent survival for cutaneous and ocular primaries. J Surg Oncol. 2013;108:129–135.
  • Pawlik TM, Zorzi D, Abdalla EK, et al. Hepatic resection for metastatic melanoma: distinct patterns of recurrence and prognosis for ocular versus cutaneous disease. Ann Surg Oncol. 2006;13:712–720.
  • Rose DM, Essner R, Hughes TM, et al. Surgical resection for metastatic melanoma to the liver: the John Wayne Cancer Institute and Sydney Melanoma Unit experience. Arch Surg. 2001;136:950–955.
  • Chua TC, Scolyer RA, Kennedy CW, et al. Surgical management of melanoma lung metastasis: an analysis of survival outcomes in 292 consecutive patients. Ann Surg Oncol. 2012;19:1774–1781.
  • Leo F, Cagini L, Rocmans P, et al. Lung metastases from melanoma: when is surgical treatment warranted? Br J Cancer. 2000;83:569–572.
  • Huppert PE, Fierlbeck G, Pereira P, et al. Transarterial chemoembolization of liver metastases in patients with uveal melanoma. Eur J Radiol. 2010;74:e38–e44.
  • Gonsalves CF, Eschelman DJ, Sullivan KL, et al. Radioembolization as salvage therapy for hepatic metastasis of uveal melanoma: a single-institution experience. Am J Roentgenol. 2011;196:468–473.
  • Sato T. Locoregional management of hepatic metastasis from primary uveal melanoma. Semin Oncol. 2010;37:127–138.
  • Shibayama Y, Namikawa K, Sone M, et al. Efficacy and toxicity of transarterial chemoembolization therapy using cisplatin and gelatin sponge in patients with liver metastases from uveal melanoma in an Asian population. Int J Clin Oncol. 2017;22:577–584.
  • Valpione S, Aliberti C, Parrozzani R, et al. A retrospective analysis of 141 patients with liver metastases from uveal melanoma: a two-cohort study comparing transarterial chemoembolization with CPT-11 charged microbeads and historical treatments. Melanoma Res. 2015;25:164–168.
  • Carling U, Dorenberg EJ, Haugvik SP, et al. Transarterial chemoembolization of liver metastases from uveal melanoma using irinotecan-loaded beads: treatment response and complications. Cardiovasc Intervent Radiol. 2015;38:1532–1541.
  • Fiorentini G, Aliberti C, Del Conte A, et al. Intra-arterial hepatic chemoembolization (TACE) of liver metastases from ocular melanoma with slow-release irinotecan-eluting beads. Early results of a phase II clinical study. In Vivo. 2009;23:131–137.
  • Tulokas S, Maenpaa H, Peltola E, et al. Selective internal radiation therapy (SIRT) as treatment for hepatic metastases of uveal melanoma: a Finnish nation-wide retrospective experience. Acta Oncol. 2018;57:1373–1380.
  • Faries MB, Leung A, Morton DL, et al. A 20-year experience of hepatic resection for melanoma: is there an expanding role? J Am Coll Surg. 2014;219:62–68.
  • Derek E, Matsuoka L, Alexopoulos S, et al. Combined surgical resection and radiofrequency ablation as treatment for metastatic ocular melanoma. Surg Today. 2013;43:367–371.
  • Schumacher G, Eisele R, Spinelli A, et al. Indications for hand-assisted laparoscopic radiofrequency ablation for liver tumors. J Laparoendosc Adv Surg Tech A. 2007;17:153–159.
  • Siperstein A, Garland A, Engle K, et al. Laparoscopic radiofrequency ablation of primary and metastatic liver tumors. Technical considerations. Surg Endosc. 2000;14:400–405.
  • Bleicher RJ, Allegra DP, Nora DT, et al. Radiofrquency ablation in 447 complex unresectable liver tumors: lessons learned. Ann Surg Oncol. 2003;10:52–58.
  • Steinke K, Glenn D, King J, et al. Percutaneous pulmonary radiofrequency ablation: difficulty achieving complete ablations in big lung lesions. Br J Radiol. 2003;76:742–745.
  • Bale R, Schullian P, Schmuth M, et al. Stereotactic radiofrequency ablation for metastatic melanoma to the liver. Cardiovasc Intervent Radiol. 2016;39:1128–1135.
  • Chua TC, Glenn D, Morris DL. Extending the survival of patients with melanoma lung metastases through radiofrequency ablation. Acta Oncol. 2010;49:517–519.
  • Boursault L, Scasso A, Laumonier H, et al. [Two cases of pulmonary melanoma metastasis treated with radiofrequency: an alternative to surgical excision]. Ann Dermatol Venereol. 2010;137:799–802.
  • Steels E, Donckier V, Flamen P, et al. Long‐term benefit of combined radiofrequency ablation and surgery in a patient with AJCC stage IV metastatic melanoma. Clin Exp Dermatol. 2007;32:100–101.
  • Mayo‐Smith WW, Dupuy DE. Adrenal neoplasms: CT-guided radiofrequency ablation-preliminary results. Radiology. 2004;231:225–230.
  • Testori A, Ribero S, Bataille V. Diagnosis and treatment of in-transit melanoma metastases. Eur J Surg Oncol. 2017;43:544–560.
  • Rauch A, Cazzato RL, Garnon J, et al. MRI-guided cryoablation of in-transit metastases from cutaneous melanoma: a brief report on a preliminary experience. Cardiovasc Intervent Radiol. 2017;40:1285–1289.